The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 19, 2020

Filed:

Oct. 17, 2016
Applicants:

Arizona Board of Regents on Behalf of the University of Arizona, Tucson, AZ (US);

The Texas A&m University System, College Station, TX (US);

Inventors:

Victor J. Hruby, Tucson, AZ (US);

Minying Cai, Tucson, AZ (US);

Caurnel Morgan, College Station, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 49/00 (2006.01); A61B 5/00 (2006.01); A61K 35/30 (2015.01); A61K 31/54 (2006.01); C07K 7/08 (2006.01); C07K 14/685 (2006.01); A61K 38/08 (2019.01); A61K 9/00 (2006.01); A61K 38/10 (2006.01); A61K 38/17 (2006.01); C07K 14/68 (2006.01); C07K 14/72 (2006.01); A61K 38/12 (2006.01); A61K 47/24 (2006.01); C07K 7/06 (2006.01); C07D 473/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/08 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 38/10 (2013.01); A61K 38/12 (2013.01); A61K 38/177 (2013.01); A61K 47/24 (2013.01); C07D 473/00 (2013.01); C07K 7/06 (2013.01); C07K 7/08 (2013.01); C07K 14/68 (2013.01); C07K 14/685 (2013.01); C07K 14/723 (2013.01); G01N 2333/72 (2013.01); G01N 2500/10 (2013.01);
Abstract

Compositions and methods for treating a depressive disorder or an anxiety disorder in a subject in need of such treatment are described. A therapeutically effective amount of a composition comprising compound PG-20N in a pharmaceutically acceptable carrier is described. According to another embodiment, the subject disclosure features method of treating a depressive disorder or an anxiety disorder in a subject in need of such treatment. The method may comprise administering to the subject a therapeutically effective amount of a composition comprising PG-20N.


Find Patent Forward Citations

Loading…